Negative symptoms assessment in early intervention settings: Implications for early identification and treatment

por Glenthøj, L.B., Nielsen, M., Nordentoft, M.
Publicado 2021

Assessment of Cognitive Impairment in Early Intervention Settings

por Nordentoft, M., Glenthøj, L., Medalia, A., Roberts, D., Hjorthoj, C.
Publicado 2022

Face Your Fears: Virtual reality-based cognitive behavioral therapy (VR-CBT) versus standard CBT for paranoid ideations in patients with schizophrenia spectrum disorders: a randomi...

por Jeppesen, U. N., Due, A. S., Mariegaard, L., Pinkham, A., Vos, M., Veling, W., Nordentoft, M., Glenthøj, L. B.
Publicado 2022

CHALLENGE and Face Your Fears: Virtual Reality Treatment for Auditory Hallucinations and Paranoid Ideations

por Glenthøj, L., Smith, L., Mariegaard, L., Due, A.S., Christensen, A., Christensen, M., Vernal, D., Jeppesen, U., Nordentoft, M.
Publicado 2022

Update to the study protocol Face Your Fears: Virtual reality-based cognitive behavioral therapy (VR-CBT) versus standard CBT for paranoid ideations in patients with schizophrenia...

por Jeppesen, U. N., Due, A. S., Mariegaard, L., Pinkham, A., Vos, M., Veling, W., Nordentoft, M., Glenthøj, L. B.
Publicado 2023

The CHALLENGE trial: the effects of a virtual reality-assisted exposure therapy for persistent auditory hallucinations versus supportive counselling in people with psychosis: study...

por Smith, L. C., Mariegaard, L., Vernal, D. L., Christensen, A. G., Albert, N., Thomas, N., Hjorthøj, C., Glenthøj, L. B., Nordentoft, M.
Publicado 2022

EPA guidance on treatment of negative symptoms in schizophrenia

por Galderisi, S., Kaiser, S., Bitter, I., Nordentoft, M., Mucci, A., Sabé, M., Giordano, G. M., Nielsen, M. Ø., Glenthøj, L. B., Pezzella, P., Falkai, P., Dollfus, S., Gaebel, W.
Publicado 2021

EPA guidance on assessment of negative symptoms in schizophrenia

por Galderisi, S., Mucci, A., Dollfus, S., Nordentoft, M., Falkai, P., Kaiser, S., Giordano, G. M., Vandevelde, A., Nielsen, M. Ø., Glenthøj, L. B., Sabé, M., Pezzella, P., Bitter, I., Gaebel, W.
Publicado 2021

Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months

por Wenneberg, C., Glenthøj, B. Y., Glenthøj, L. B., Fagerlund, B., Krakauer, K., Kristensen, T. D., Hjorthøj, C., Edden, R. A. E., Broberg, B. V., Bojesen, K. B., Rostrup, E., Nordentoft, M.
Publicado 2020